Payare L. Sangwan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Payare L. Sangwan has a total of 66 co-authors. Here are the top co-authors by number of shared publications:
Nidhi Gupta
Bioorganic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu, 180001, India
8 shared publicationsJasvinder Singh
Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine, Jammu 180001, India; Academy of Scientific and Innovative Research (AcSIR), CSIR-IIIM Campus, Jammu, India
6 shared publications- Praveen K. Chinthakindi
Bioorganic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Canal Road, Jammu 180001, India
6 shared publications Santosh K. Rath
Bioorganic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Canal Road Jammu, 180001, India; Academy of Scientific and Innovative Research (AcSIR), CSIR-IIIM Campus, Jammu 180001, India
6 shared publications- Alamgir Ahmad Dar
Research Centre for Residue and Quality Analysis (RCRQA), Faculty of Horticulture, Sher-e-Kashmir University of Agricultural Sciences and Technology of Kashmir, Shalimar, Srinagar, India
5 shared publications Arem Qayum
Cancer Pharmacology Division, CSIR-Indian Institute of Integrative Medicine Jammu, 180001, India; Academy of Scientific and Innovative Research (AcSIR), CSIR-IIIM Campus, Jammu, India
4 shared publications
Latest Publications
- Open Access
- 25 June 2020
- Published by AOSIS in Journal of Medicinal Plants for Economic Development
- Vol. 4 (1) , 5
Comparative in-vitro anticancer and brine shrimp cytotoxic activities of Mezoneuron benthamianum Baill.
Background: Cancer is one of the leading causes of global mortality and recently, it has been established that there is a link between periodontal disease and various types of cancer. In Nigeria, chewing sticks are used especially in the rural areas to maintain oral hygiene and to prevent periodontal disease. Mezoneuron benthamianum is a plant that is used locally as a chewing stick in the southwest of Nigeria, but there has been no report on its anticancer properties. Aim: This study is aimed at determining the anticancer activity using sulforhodamine B (SRB) assay and brine shrimp cytotoxic activity of the extracts of M. benthamianum. Setting: The roots of M. benthamianum were obtained from Ibadan, Oyo State, Nigeria, and were identified and authenticated at the University of Ibadan Herbarium. Methods: The plant sample was subsequently dried, pulverised and extracted with hexane, dichloromethane, ethyl acetate and methanol to give the different extracts which were tested against four cell lines (Lung A549, Lung NCI-H322, Breast T47D and Prostate PC-3) using the SRB assay and were also evaluated against brine shrimp nauplii. Results: The results of the study showed that the different extracts of M. benthamianum had selective and consistent cytotoxic activity against the Lung (A549), Lung (NCI-H322) and Breast (T47D) cell lines, having a percentage growth inhibition ranging from 36% to 63%. The hexane and dichloromethane extracts also gave LC50 values of 99.96 and 29.29 against brine shrimp cytotoxic activity. Conclusion: These results justify the use of M. benthamianum in folkloric medicine.
- 25 June 2020
- Published by AOSIS in Journal of Medicinal Plants for Economic Development
- Vol. 4 (1) , 5
Open AccessComparative in-vitro anticancer and brine shrimp cytotoxic activities of Mezoneuron benthamianum Baill.
Background: Cancer is one of the leading causes of global mortality and recently, it has been established that there is a link between periodontal disease and various types of cancer. In Nigeria, chewing sticks are used especially in the rural areas to maintain oral hygiene and to prevent periodontal disease. Mezoneuron benthamianum is a plant that is used locally as a chewing stick in the southwest of Nigeria, but there has been no report on its anticancer properties. Aim: This study is aimed at determining the anticancer activity using sulforhodamine B (SRB) assay and brine shrimp cytotoxic activity of the extracts of M. benthamianum. Setting: The roots of M. benthamianum were obtained from Ibadan, Oyo State, Nigeria, and were identified and authenticated at the University of Ibadan Herbarium. Methods: The plant sample was subsequently dried, pulverised and extracted with hexane, dichloromethane, ethyl acetate and methanol to give the different extracts which were tested against four cell lines (Lung A549, Lung NCI-H322, Breast T47D and Prostate PC-3) using the SRB assay and were also evaluated against brine shrimp nauplii. Results: The results of the study showed that the different extracts of M. benthamianum had selective and consistent cytotoxic activity against the Lung (A549), Lung (NCI-H322) and Breast (T47D) cell lines, having a percentage growth inhibition ranging from 36% to 63%. The hexane and dichloromethane extracts also gave LC50 values of 99.96 and 29.29 against brine shrimp cytotoxic activity. Conclusion: These results justify the use of M. benthamianum in folkloric medicine.
- 1 January 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 27 (2) , 343-353
Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus
- 1 January 2019
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 27 (2) , 343-353
Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus
- 1 February 2018
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 145, 511-523
Synthesis and biological evaluation of novel bavachinin analogs as anticancer agents
- 1 February 2018
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 145, 511-523
Synthesis and biological evaluation of novel bavachinin analogs as anticancer agents
- 1 July 2017
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 135, 517-530
Synthesis of novel benzylidene analogues of betulinic acid as potent cytotoxic agents
- 1 July 2017
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 135, 517-530
Synthesis of novel benzylidene analogues of betulinic acid as potent cytotoxic agents
- 22 June 2017
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 26 (10) , 2499-2513
Isolation of isoxanthanol and synthesis of novel derivatives as potential cytotoxic agents
- 22 June 2017
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 26 (10) , 2499-2513
Isolation of isoxanthanol and synthesis of novel derivatives as potential cytotoxic agents
- 21 June 2017
- Published by Wiley in ChemistrySelect
- Vol. 2 (18) , 5196-5201
Synthesis of Novel Mannich Derivatives of Bakuchiol as Apoptotic Inducer through Caspase Activation and PARP‐1 Cleavage in A549 Cells
A new series of bakuchiol 1 Mannich derivatives was synthesized by reaction with various substituted secondary amines. The analogs were evaluated for cytotoxicity against a panel of three different human cancer cell lines breast (MCF‐7), colon (HCT‐116) and lung (A549). Cytotoxicity screening results showed that many compounds displayed significant in vitro cytotoxic effects against different cancer cell lines. Compounds 9, 12, 14, 16, 17 and 21 showed promising cytotoxic effects compared to parent molecule 1 and among them compound 14 was found to be most potent analog with IC 50 5 μM against all the cell lines examined. It was about 8‐fold more potent against MCF‐7 and A549 and 10‐fold more potent against HCT‐116 cell line in comparison to the parent molecule 1. Structure activity relationship (SAR) study of all synthesized derivatives was carried out. Further, compound 14 induced apoptosis in lung cancer cells (A549) through caspase activation followed by PARP‐1 cleavage.
- 21 June 2017
- Published by Wiley in ChemistrySelect
- Vol. 2 (18) , 5196-5201
Synthesis of Novel Mannich Derivatives of Bakuchiol as Apoptotic Inducer through Caspase Activation and PARP‐1 Cleavage in A549 Cells
A new series of bakuchiol 1 Mannich derivatives was synthesized by reaction with various substituted secondary amines. The analogs were evaluated for cytotoxicity against a panel of three different human cancer cell lines breast (MCF‐7), colon (HCT‐116) and lung (A549). Cytotoxicity screening results showed that many compounds displayed significant in vitro cytotoxic effects against different cancer cell lines. Compounds 9, 12, 14, 16, 17 and 21 showed promising cytotoxic effects compared to parent molecule 1 and among them compound 14 was found to be most potent analog with IC 50 5 μM against all the cell lines examined. It was about 8‐fold more potent against MCF‐7 and A549 and 10‐fold more potent against HCT‐116 cell line in comparison to the parent molecule 1. Structure activity relationship (SAR) study of all synthesized derivatives was carried out. Further, compound 14 induced apoptosis in lung cancer cells (A549) through caspase activation followed by PARP‐1 cleavage.
- 1 February 2017
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 127, 1047-1058
Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships
- 1 February 2017
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 127, 1047-1058
Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationships
- 1 December 2016
- Published by Elsevier in Phytochemistry
- Vol. 132, 102-108
Biologically active xanthones from Codonopsis ovata
- 1 December 2016
- Published by Elsevier in Phytochemistry
- Vol. 132, 102-108
Biologically active xanthones from Codonopsis ovata
- 11 November 2016
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 8 (1) , 211-219
T- and B-cell immunosuppressive activity of novel α-santonin analogs with humoral and cellular immune response in Balb/c mice
In continuation of our endeavours to synthesize immunosuppressive agents from α-santonin, we report herein the design and synthesis of a new series of α-santonin derived O-aryl/aliphatic ether, ester and amide analogs and the evaluation of their immunosuppressive activities. The in vitro studies led to several analogs with significant immunosuppressive effects by inhibiting ConA and LPS stimulated T- and B-cell proliferation in a dose dependent manner. The more significant compounds 4d, 4e, 4f, 4h, 6a and 6b displayed potent inhibitory activity on the mitogen-induced T- and B-cell proliferation in comparison to α-santonin 1. Compound 4e displayed stupendous in vitro immunosuppressive effects with ∼80% suppression of B and ∼75% suppression of T lymphocyte proliferation, respectively. The in vivo investigation on BALB/c mice revealed that non-cytotoxic compound 4e suppresses both humoral and cellular immunity.
- 11 November 2016
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 8 (1) , 211-219
T- and B-cell immunosuppressive activity of novel α-santonin analogs with humoral and cellular immune response in Balb/c mice
In continuation of our endeavours to synthesize immunosuppressive agents from α-santonin, we report herein the design and synthesis of a new series of α-santonin derived O-aryl/aliphatic ether, ester and amide analogs and the evaluation of their immunosuppressive activities. The in vitro studies led to several analogs with significant immunosuppressive effects by inhibiting ConA and LPS stimulated T- and B-cell proliferation in a dose dependent manner. The more significant compounds 4d, 4e, 4f, 4h, 6a and 6b displayed potent inhibitory activity on the mitogen-induced T- and B-cell proliferation in comparison to α-santonin 1. Compound 4e displayed stupendous in vitro immunosuppressive effects with ∼80% suppression of B and ∼75% suppression of T lymphocyte proliferation, respectively. The in vivo investigation on BALB/c mice revealed that non-cytotoxic compound 4e suppresses both humoral and cellular immunity.